IC8 Concepts for Sterility Flashcards

1
Q

Sterility is defined by WHO as the absence o viable microorganism. Why absolute sterility not achievable?

A

Conditions that guarantee absolute sterility are too harsh for active ingredients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is sterility assurance level (SAL)?

A

1 in 10^6 probability of viable microorganism in the drug product

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 3 criteria for sterility?

A
  1. No microorganism
  2. Endotoxins within limit
  3. No detectable particles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sterility is a requirement for ____, _____, and _____

A

Parenteral preparations, eye preparations and preparations for irrigation (to clean wound)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why must bioburden be minimized in manufacturing steps before sterilization?

A

High bioburden is critical because:
- Higher risk of contamination with viable microorganisms
- Higher risk for contamination with pyrogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is inactivation factor?
What is overkill approach?

A

Degree to which viable organisms is reduced by sterilization treatment applied

Overkill approach - sterilization process to reduce microorganism by 10^12
*Most materials unable to withstand harsh sterilization process to achieve 12 log reduction, intensity and duration of sterilization treatment may be too high to tolerate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain the validation of sterility test (suitability test) *it is a final sterility test

A

**Done after neutralization of the sterile pdt to validate the sterility test

Test sample is spiked with known quantities (<100 CFU) of known microorganisms
Positive control without sample => contaminated with just microorganisms
Negative control => clean

Incubate for 3-5 days (slow growing organisms to be incubated longer)

If level of turbidity of test sample is comparable to positive control = sample is NOT sterile (POSITIVE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain the criteria for culture media used, in validation for sterility test (growth promotion test)

A

Culture media criteria:

  • Acceptability of each batch of medium
  • Medium is ‘fit for purpose’
  • Medium can produce consistent results
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Explain the validation of sterility test (growth promotion test) *it is a final sterility test

A

Media must support growth:
Used to confirm that each lot of growth media used can support the growth of less than 100 viable microorganisms

Media must be sterile:
The media must be incubated and assessed for sterility according to the incubation parameters (time, temp) established by the method

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What might cause false negative and false positive for the validation of sterility test (growth promotion test)?

A

False negative:
- growth media unable to support growth of the indicator organism
- this affects patients* more dangerous

False positive:
- growth media was non-sterile and contained other microorganisms
- this affects facility/manufacturer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe endotoxin test? (LAL test)

A

Limulus Amoebocyte Lysate Test
- Blood extracted from horseshoe crab contains a clottable protein (derived from lysis of the blood)
- Blood coagulates in presence of bacterial endotoxins
- end point: gel, cloudy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why is endotoxin undesirable in product?

A

Endotoxin is a lipopolysaccharide (LPS) found in the outer membrane of gram negative bacteria, it is a pyrogen.

It can lead to release of interleukins and cytokines => pro-inflammatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is endotoxin limit concentration (ELC) calculated?

*ELC gives the max amount of endotoxins that can be present in a product

A

ELC = K/M,

where K = max endotoxins dose, usually 5 EU/kg
M = maximum recommended dose (max dose/kg/h)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is ELC used to determine the safety factor for dilution of the product?

A

First, maximum valid dilution (MVD) is determined via:
MVD = ELC / method sensitivity
whereby, method sensitivity has a distinct value for different methods, it measures the ability to establish that such a difference is significant

Safety factor = range of working dilution b/w MVD and first dilution fitting the specs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does maximum valid dilution (MVD) of 60 mean?

A

1 part in 60 parts total dilution

If we dilute anymore than this, we cannot determine the endotoxin limit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is bioburden/IPC (in process control) testing? *test conducted to ensure microbial control during manufacturing, thus ensuring pdt quality and safety

*It establishes the accepted limits for number of CFU and sample test volume
State what is the acceptable microorganism count based on EMA

A

Test microbial load at sterile filtration step, before aseptic filling and processing

IPC bioburden sample is drawn immediately prior to sterile filtration step, must be within accepted limits for number of CFU and sample test volume

*EMA: not more than 10CFU/100mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are some methods to reduce bioburden?

A
  1. reduce microbial load prior to and on sterile filter
  2. limit hold times and room temp storage
  3. implement aseptic handling techniques
  4. select and validate sterile filter membrane (high microbial retention capabilities >=10^6 CFU/cm^2)
  5. increase effective filter surface area - use larger filter/use multiple filters in series
  6. limit batch volume to be sterile filtered (but small yield of pdt)
  7. test integrity of sterilizing filters pre and post use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How to calculate bioburden?

A

LogN = LogNo - k*t

k is the death rate constant (gradient of downslope), No is the initial number of cells, N is the number of cells at time t

Rearrange:
Log (N/No) = -kt

To achieve 1 log reduction,
Log (1/10) = -kD
D = 1/k

To achieve SAL (6 log reduction),
t = D * (LogNo - LogSAL)

Therefore we can calculate time taken to achieve 6 log reduction in microbial load
=> If t is too long, means need to find ways to increase k in order to shorten the time
=> incr k is achieved by reducing bioburden

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the two particle count tests to evaluate sub-visible/visible particles in product?

A
  1. Light obscuration particle count test (*preferred method for injections)
  2. Microscopic particle count test
20
Q

Describe the light obscuration particle count test

A

Suitable apparatus based on principle of light blockage which allows automatic determination of the SIZE and NUMBER of particles

Apparatus is calibrated using dispersions of spherical particles of known sizes between 10um and 25um

21
Q

How are parenteral samples drawn and used for the light obscuration particle count test?

A

Large volume parenterals: test single units

Small volume parenterals <25ml: combine contents of 10 or more units and obtain volume of at least 25ml

Powders for parenteral: reconstituted with particle-free water or appropriate solvent

22
Q

Describe the microscopic particle count test

A

Microscope equipped with ocular micrometer which consist of a large circle divided by crosshairs into quadrants, transparent and black reference circles 10um and 25um in diameter

23
Q

When using light obscuration and microscopic particle count test, preparation complies with the test if:

A

Average no. of sub visible particles present in the units tested

does not exceed 6000 >= 10um per container
AND
does not exceed 600 >= 25um per container

Should be free of visible particles

24
Q

What is Aseptic Process Simulation (APS)?

A

Substitute product with microbiological growth medium in order to validate the aseptic process

Involves using microbiological growth promoting media in place of the product to undergo aseptic process, media is then incubated and inspected for microbial growth

Selection of nutrient medium should be made based on dosage form of the pdt, and selectivity, clarity, concentration, and suitability for sterilization of the nutrient medium

25
Q

What are the advantages and disadvantages of APS?

A

Advantages:
- Define routine procedures, assess manufacturing steps
- Can use non-ideal conditions, create safety margin when system works with non-ideal conditions

Disadvantages:
- ‘point-in-time’ evaluation, need to check which step went wrong
- not QA
- need risk assessment and worst-case scenario

26
Q

Sterility Method 1: Aseptic Filtration
How is aseptic filtration done?
- What size is the filter, what can it remove, what can’t it remove

A

Use 0.22um filter
=> ‘bacteria retentive filter’ can remove bacteria and molds, but not all viruses or mycoplasmas (require additional heat treatment)
=> unable to filter ions as well

=> can remove pyrogens

27
Q

Sterility Method 1: Aseptic Filtration

Aseptic filtration is done with minimum conc. of ____ for which standard organism?

Why is this so?

A

Minimum concentration of 10^7 CFU/cm2

Use high conc. of standard test organism (Brevundimonas diminuta), so that if system works with high bioburden, it will work when actual bioburden is lower

28
Q

Sterility Method 1: Aseptic Filtration
What are some considerations for the sterilized filter used?

A

Integrity of sterile filter
- should be verified for volume and filtrate load
- fibre-shedding from filter should be minimal
- filter should not rupture (filter integrity test)

*Asbestos-containing filters should not be used

Filter should not remove any ingredients from the formulation or release any substances into the formulation

*Final sterile filtration is advised to be done immediately before filling, preferably using double-filter layer or second filtration

29
Q

How is APS done for liquids (e.g., liquids that undergo aseptic filtration)?

A

During compounding/solution preparation step:
- Sterile medium should come into contact with every surface/piece of equipment involved in the process (*medium should come into contact longer than final product)
- Include routine tests such as filter functionality assessment, holding time, sampling

During filling step:
- Medium should come into contact with the whole container + cap (shake)
- Container should be transparent to inspect, size must be consistent with the product and process

30
Q

Sterility Method 2: Lyophilization
What is lyophilization and how is it done?

A

Lyophilization is the process in which water is removed from the product after it is frozen and placed under a vacuum, allowing ice to change directly from solid to vapor without passing liquid phase.

It is carried out in aseptic conditions

  1. Dissolve drug and excipient in suitable solvent/diluent, generally WFI
  2. Sterilize bulk solution by passing it through 0.22um filter
  3. Fill into sterile containers, partially stopper
    - do not close completely as subsequent evaporation
    - do not open due to contamination risk
  4. Transport partially stoppered container to lyophilizer
  5. Freeze the solution in freeze-drying chamber
  6. Apply vacuum to chamber and heat the shelves in order to evaporate the water from the frozen state
  7. Complete stoppering of the vials by hydraulic or screw rod stoppering
    - *pdt is hygroscopic, stopper in low humidity environment

*Transfer of partially closed containers should be undertaken in Grade A environment

31
Q

Sterility Method 2: Lyophilization

What are the three separate and interdependent processes involved?

A
  1. Freezing
    *Take note of possible polymorphism due to crystallization => may affect solubility (physicochemical property) and reconstitution of final pdt
  2. Primary drying (sublimation)
    - Done under vacuum with heat
    - Temp should be stable during sublimation
    - Temp rise indicates end point (all water removed, pdt now being heated)
  3. Secondary drying (desorption)
    - Desorption refers to water being adsorbed onto the crystal/particle
    - The presence of water can result in stability issues
    - Hence desorption of water under vacuum can detach water from the crystal
    - End point = water content <1%
32
Q

What are some advantages and disadvantages of lyophilization?

A

Advantages:
- Ease of processing a liquid
- Stability in lyophilized form

Disadvantages:
- Expensive
- Requires sterile diluent (for reconstitution)

33
Q

How is APS done for lyophilization?

A

Simulated lyophilization
- Container filled with growth medium loaded onto lyostat, vacuum applied (can be comparable or less than the real one for the same time)
=> condition worse than one we expect (e.g., lower time and vacuum) can give safety margin

Issues (affect growth of microorganisms):
- vacuum and time: boiling out of aerobic microorganisms?
- growth of anaerobic organism need to use inert gas instead of O2 (cost?)

34
Q

What are some considerations when performing APS for lyophilization?

A
  1. CIP/SIP (clean in place, sterilization in place) consolidated practice
    - since cleaning of system is involved
  2. Set up can be performed before sterilization
    - set up procedure require several steps, also set up procedure for cleaning of system
  3. Long holding times can produce product sticking
  4. Product formulation is usually prepared just before filling
  5. Batch dimension can be limited by storage tank size (size depend on equipment)
35
Q

What are two alternatives to lyophilization to obtain sterile powders?

A
  1. Sterile recrystallization
    - drug is dissolved in a solvent and the obtained solution sterilized through 0.22um membrane filter
    - sterile antisolvent added to crystallize the drug particles, which are then filtered and dried aseptically
    disadvantage: may have variations between batches
  2. Spray drying
    - solution of drug sprayed into dry chamber where it comes into contact with hot steam of a sterile gas (80-100dc)
36
Q

How is APS done for powder?

A

Filling step:
- filling machine can do two consecutive filling, medium and placebo powder dissolved in it

*placebo powder:
- should have similar mechanical properties to the pdt
- easy to sterilise
- soluble in the medium (e.g., lactose, mannitol, PEG, NaCl)
- no effect on growth medium (test using growth promotion test)

Negative control - medium without placebo

37
Q

What are some considerations when performing APS for powders?

A
  • CIP/SIP not applicable since no cleaning of systems involved
  • dose/QC parts are aseptically assembled
  • set up is longer than for liquid
  • during holding times, product can remain in machine without sticking
  • blending is usually prepared off-line
  • batch dimension is not limitation
  • presence of powder requires interventions for cleaning
  • machine tuning may require human interventions - operator source of contamination
38
Q

What medium can be used for APS (powder)?

A

Soybean casein digest medium or Trypticase Soy Broth (TSB) for aerobic microorganism, fungi, yeast

Fluid thioglicollate medium (FTM) for anaerobic microorganisms

Sabouraud Dextrose Agar (SDA) for yeast

39
Q

What outcomes are assessed for ASP (powder)?

A

Visual inspection to spot contamination/turbidity
- Performed after incubation at 20-35dc for 14 days (or at least 7 days with two sep temp)
- Perform at half-time and end of incubation period

Counting and identification
- Check morphology

Supervision via QA

40
Q

Discuss the limitations of water for injection as a sterile diluent

A

While WFI minimizes the possibility of toxicity and chemical reactions,

  • its use is limited if drug has limited solubility (large volume WFI required)
  • instability of aqueous solution
41
Q

Apart from WFI, what are some alternatives for sterile diluents?

A
  1. Fixed oils (corn, cottonseed oil)
  2. Ethyl oleate, isopropyl myristate
  3. Ethanol (cannot use at high extent, cause pain, hemolytic at high conc.)
  4. Dimethyl sulfoxide (work well with low solubility drug, but hemolytic and toxic at low conc.)
  5. PEG
42
Q

What are the requirements for sterile injection?

A
  1. Sterile and bacteria endotoxin below allowable limits
  2. Standards for particulate matter
  3. Restricted use of additives (additives must be compatible)
  • Additives include: vehicle, preservatives, tonicity adjusting agents, buffers, antioxidants, dispersing agents and surfactants
43
Q

Epidurals (intrathecal) must be _____ free as it can cause paralysis

A

preservative-free

44
Q

List some sterile products

A

Sterile powder
Injections
IV bags
Multi-dose vials
Patient-controlled analgesia
Epidural (intrathecal)
Irrigation
Albumin
Plasma protein fraction Ppf
Immunoglobulin (lyophilized)
Ophthalmic

45
Q

Disinfectants used in which grade areas should be sterile before use?

A

Grade A and B

*Grade A: high-risk operations e.g., filling and making aseptic connections, should have unidirectional airflow